Professor Chris Porter, PhD


Member of the LFCS Consortium: Digestion and Dispersion

Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, Parkville campus, Melbourne, Australia


Chris Porter is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Associate Dean (Research) of the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Melbourne. He completed his undergraduate and graduate studies at the University of Nottingham in the UK before moving to Australia and Monash in 1992. Subsequently, Chris’ research program has focused on understanding and quantifying drug absorption, distribution and elimination profiles and on developing the models and techniques to probe these interactions. A major interest has been the issues and problems surrounding the absorption of poorly water soluble, highly lipophilic drugs and in particular the use of lipid based delivery systems to enhance oral bioavailability and stimulate lymphatic transport. In 2009 Chris was awarded the American Association of Pharmaceutical Scientists (AAPS) lipid based drug delivery outstanding research award in recognition of his efforts in this area. More recently, his interests have also expanded into the mechanisms of cellular transport of lipophilic drugs and the potential utility of dendrimers as drug delivery systems. Chris has published more than 100 peer reviewed papers and has received in excess of $6m in funding from both government and the commercial sector. He is a current member of the Editorial Boards of Pharmaceutical Research, the Journal of Pharmaceutical Sciences and the Journal of Pharmacy and Pharmacology.

Consortium members include Full Members, Associate Members and Universities: